Issue of Equity | 02-Dec-2022 | 17:30 | RNS |
Second Price Monitoring Extn | 01-Nov-2022 | 16:41 | RNS |
Price Monitoring Extension | 01-Nov-2022 | 16:35 | RNS |
Issue of Equity | 21-Oct-2022 | 18:15 | RNS |
Streamlining of operations to increase cash runway | 18-Oct-2022 | 07:00 | RNS |
TR-1: Notification of major holdings | 17-Oct-2022 | 14:23 | RNS |
TR-1: Notification of major holings | 17-Oct-2022 | 14:23 | RNS |
Holding(s) in Company | 30-Sep-2022 | 17:30 | RNS |
Issue of Equity | 30-Sep-2022 | 17:30 | RNS |
Interim Results | 29-Sep-2022 | 07:00 | RNS |
Positive headline results from ovarian study | 29-Sep-2022 | 07:00 | RNS |
Study using Parsortix in head and neck cancer | 28-Sep-2022 | 07:00 | RNS |
New poster presented at ASCP Meeting | 13-Sep-2022 | 07:00 | RNS |
Novel assay predicts malignancy in pelvic mass | 12-Sep-2022 | 07:30 | RNS |
Notice of Interim Results and Webcast | 01-Sep-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 19.25p |
Change Today | -0.25p |
% Change | -1.28 % |
52 Week High | 31.40 |
52 Week Low | 9.25 |
Volume | 366,342 |
Shares Issued | 260.58m |
Market Cap | £50.16m |
RiskGrade | 312 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:24 | 38,000 @ 19.32p |
16:24 | 38,000 @ 19.12p |
16:21 | 20,000 @ 19.32p |
16:17 | 5,983 @ 19.32p |
14:36 | 9,000 @ 19.33p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research